Laura Feeney

3PUBLICATIONS
55CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 13, 2026
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.

Xiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu

|Aug 26, 2024
The MRE11-RAD50-NBS1 complex both starts and extends DNA end resection in mouse meiosis.

Soonjoung Kim, Shintaro Yamada, Tao Li

|Nov 08, 2023
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study.

Yvette Drew, Jae-Weon Kim, Richard T Penson

Pageof 1